Foundery Immune Studio

Foundery Immune Studio is a South San Francisco-based biotechnology venture studio focused on the discovery and development of first-in-class immunotherapies for oncology and autoimmune diseases. The company employs a unique "studio" model, leveraging a proprietary platform to identify and validate novel immune targets through deep biological insights and advanced screening technologies. Foundery was founded by a team of experienced drug developers and academic leaders, including pioneers from the University of California, San Francisco. Their strategy involves advancing programs through the discovery phase to establish proof-of-concept, subsequently partnering with large pharmaceutical companies or spinning off new entities. Notably, the studio has established a significant multi-target collaboration with Regeneron Pharmaceuticals to develop treatments for inflammatory conditions.